US pharma major AbbVie has announced a deal with Xilio Therapeutics, more than doubling the latter’s share price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback